Drug Repurposing opportunities arise from potential observations, discussions, and collaborations, including the development of different meaningful platforms for the identification of drugs and their potential targets and allow the accessing of compounds. Drug Repurposing is an approach that uses the existing approved/failed drug for novel clinical use. This approach has the advantage that the compounds have already undergone different drug discovery phases and have sufficient information related to safety, efficacy, formulation, dose, and potential toxicity. As a result, this strategy is gaining considerable attention in the area of drug research because of its cost-effective and time-saving capabilities. In recent years many pharmaceuticals are utilizing this approach for their drug discovery and development program, in fact in the Covid-19 era, its utility increased by many folds.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report